Abivax SA American Depositary Shares (ABVX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Abivax SA American Depositary Shares, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Abivax SA American Depositary Shares (ABVX) has returned -17.43% so far this year and 1,681.60% over the past 12 months.

Based on dividend-adjusted daily data since Oct 20, 2023, ABVX's average daily return is +1.13%, while the average monthly return is +30.11%. At this rate, your investment would double in approximately 0.2 years.

Historically, 60% of months were positive and 40% were negative. The best month was Jul 2025 with a return of +838.2%, while the worst month was Mar 2025 at -18.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ABVX closed higher 49% of trading days. The best single day was Jul 23, 2025 with a return of +586.0%, while the worst single day was Mar 10, 2025 at -18.7%.

Abivax SA American Depositary Shares has an annualized alpha of 1142.52%, beta of 1.66, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 23, 2023.

• This stock captured 687.27% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -78.26%) — a profile typical of hedging or uncorrelated assets.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ABVX ranks 99 for risk / return — in the top 99% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Abivax SA American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abivax SA American Depositary Shares was 67.46%, occurring on Apr 8, 2025. Recovery took 72 trading sessions.

The current Abivax SA American Depositary Shares drawdown is 23.37%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Abivax SA American Depositary Shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Abivax SA American Depositary Shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.